• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Home
  • About Us
  • Contact US
  • Privacy Policy
  • Terms and Conditions

Web Blogging

SEO Guides & Tips

  • Home
  • SEO Guides
  • Rankings
  • Keywords
  • Search Engines
  • Quality Content
  • Marketing

vaccines

Covid virus, vaccines does not enter human DNA: Study

August 1, 2021 by admin Leave a Comment

[ad_1]

SYDNEY: Covid-19 cannot enter a person’s DNA, say Australian researchers refuting claims of SARS-CoV-2, the virus that caused the infectious disease, integrating its genetic material into the human genome.
The study, published in the journal Cell Reports, showed there was no evidence of Covid-19 — or the Pfizer or AstraZeneca vaccines — entering DNA.
The claims have led to “scaremongering” and people should not hesitate to be vaccinated, said researchers from University of Queensland.
The research confirmed there was no unusual viral activity and the Covid-19 behaviour was in line with what was expected from a coronavirus.
“The evidence refutes this concept being used to fuel vaccine hesitancy,” said Geoff Faulkner, Professor at the varsity’s Queensland Brain Institute.
“We find no evidence of SARS-CoV-2 integration suggests such events are, at most, extremely rare in vivo, and therefore are unlikely to drive oncogenesis or explain post-recovery detection of the virus.
“From a public health point of view, we would say that there are no concerns that the virus or vaccines can be incorporated into human DNA,” Faulkner said.
In his previous research, published in the Proceedings of the National Academy of Sciences, Faulkner suggested that positive Covid-19 tests long after recovery are due to the virus being incorporated into DNA.
“We looked into their claims that the human cells and machinery turned Covid-19 RNA into DNA, causing permanent mutations.
“We assessed the claims in cells grown in the laboratory, conducted DNA sequencing and found no evidence of Covid-19 in DNA,” he added.
In May, researchers from the Purdue University in Indiana, US, showed that although throughout human history there have been viruses capable of integrating their genetic material into human genes, the Covid virus lacks the molecular machinery to integrate its RNA into human DNA.



[ad_2]

Source link

Filed Under: Marketing Tagged With: Covid, DNA, enter, human, study, vaccines, virus

delta variant: Pfizer, AstraZeneca vaccines protect against Delta variant: Lancet study

June 15, 2021 by admin Leave a Comment

[ad_1]

LONDON: The Delta variant of coronavirus, first identified in India, doubles the risk of hospitalisation compared with the Alpha variant first found in the UK, but Pfizer and AstraZeneca vaccines provide good protection against the strain, says a study published in The Lancet journal.
Researchers at Public Health Scotland and the University of Edinburgh, UK, found that the Pfizer-BioNTech vaccine offered better protection against the Delta variant compared to the Oxford-AstraZeneca preventive, known as Covishield in India.
The analysis covered the period from April 1 to June 6, 2021, for the demographic distribution of cases.
The team analysed 19,543 confirmed SARS-CoV-2 infections over the period of interest, of whom 377 were admitted to hospital for Covid-19 in Scotland.
Around 7,723 community cases and 134 hospitalisations were found to have the Delta variant of coronavirus.
The study found that the Pfizer vaccine offered 92 per cent protection against the Alpha variant and 79 per cent against the Delta strain two weeks after the second dose.
For AstraZeneca’s vaccine, there was 60 per cent protection against Delta compared with 73 per cent for Alpha variant, the researchers said.
They also found that two doses of vaccine provide much better protection against the Delta variant compared to a single dose.
“Risk of Covid-19 hospital admission was approximately doubled in those with the Delta variant of concern (VOC) when compared to the Alpha VOC, with risk of admission particularly increased in those with five or more relevant comorbidities,” the authors of the study noted.
“Both the Oxford–AstraZeneca and Pfizer–BioNTech Covid-19 vaccines were effective in reducing the risk of SARS-CoV-2 infection and Covid-19 hospitalisation in people with the Delta VOC,” they said.
However, the researchers noted that these effects on infection with Delta variant appeared to be diminished when compared to those with the Alpha VOC.
The authors of the study warned that the vaccine comparison should be interpreted with caution due to differences in the groups which received each type of vaccine, and also in how quickly immunity is developed with each shot.



[ad_2]

Source link

Filed Under: Marketing Tagged With: AstraZeneca, delta, Lancet, Pfizer, protect, study, vaccines, variant

Sinopharm Covid-19 vaccines appear safe, effective, says study

May 27, 2021 by admin Leave a Comment

[ad_1]

JAKARTA: Two vaccines made by China’s Sinopharm appear safe and effective against COVID-19, according to a study published in a medical journal.
Scientists had been waiting for more details about the two vaccines, even though they already are being used in many countries, and one recently won the backing of the World Health Organisation for emergency use.
The report, published online in the Journal of the American Medical Association, concluded the two vaccines are about 73 per cent and 78 per cent effective, as Sinopharm has previously claimed.
Researchers from Sinopharm and its local partners in the Middle East say the trial involved around 40,380 participants with the company’s two vaccines — one developed by the Wuhan Institute of Biological Products and the other by the Beijing Institute of Biological Products — and a placebo.
The trial was carried out in four countries — Bahrain, the United Arab Emirates, Egypt and Jordan. However, the study provided data for just Bahrain and the UAE.
“There’s nothing very surprising. It’s consistent with what they have claimed previously, but it does not completely eliminate the doubts about Sinopharm,” said Jin Dong-yan, a medical professor at the University of Hong Kong who was not involved with the study.
He raised doubts about how protective the vaccine was based on a recent surge of cases in the island nation of Seychelles, which had vaccinated a large majority of its population with the Sinopharm vaccine.
The study, performed mostly in younger men, had little information about the vaccine’s effectiveness against severe disease. Some experts also expressed concern at the shortage of female participants, with nearly 85 per cent being male.
“It’s important to make sure you have tested it in enough women to be able to start seeing any possible safety concerns,” said Ashley St. John, an associate professor at Duke-NUS Medical School in Singapore.
A spokesperson for the company did not immediately respond to a request for comment.
The vaccines, both of which are made with inactivated viruses, have already been given to millions of people across the world.
The World Health Organisation cleared the Beijing Institute of Biological Products’ shot for emergency use in early May, making it the first Chinese vaccine to receive the certification.
Chinese Foreign Minister Wang Yi said in April that China has provided vaccines to more than 100 countries, although it has not identified them. While China has six vaccines in use, the majority of its exports come from two companies: Sinopharm and Sinovac.



[ad_2]

Source link

Filed Under: Marketing Tagged With: Covid19, effective, safe, Sinopharm, study, vaccines

Pfizer, Moderna vaccines may greatly reduce risk of asymptomatic Covid-19 infection, study says

March 12, 2021 by admin Leave a Comment

[ad_1]

WASHINGTON: Patients without Covid-19 symptoms are far less likely to test positive, and unknowingly spread Covid-19 ten days after receiving a second dose of a messenger RNA vaccine, compared to those who have not been vaccinated, a study says.
Researchers from Mayo Clinic in the US noted that several vaccines are now clinically available under emergency use authorisation and have demonstrated efficacy against symptomatic Covid-19.
However, the impact of vaccines on asymptomatic SARS-CoV-2 infection is largely unknown, they said.
The Pfizer-BioNTech and Moderna messenger RNA (mRNA) vaccines for Covid-19 are authorised for emergency use in many countries.
An mRNA vaccine is based on the segments of the genetic material, or RNA, of the novel coronavirus.
With two doses of a mRNA Covid-19 vaccine, people with no symptoms showed an 80 per cent lower adjusted risk of testing positive for the disease after their last dose, according to the researchers.
The findings, published in the journal Clinical Infectious Diseases, underscore the efficacy of mRNA vaccines for Covid-19 to significantly limit the spread of Covid-19 by people with no symptoms who may unknowingly spread the infection to others.
“We found that those patients without symptoms receiving at least one dose of the first authorised mRNA Covid-19 vaccine, Pfizer-BioNTech, 10 days or more prior to screening were 72 per cent less likely to test positive,” said Aaron Tande, a Mayo Clinic infectious diseases specialist and co-first author of the paper.
“Those receiving two doses were 73 per cent less likely, compared to the unvaccinated group,” Tande said.
After adjusting for a range of factors, researchers found an 80 per cent risk reduction of testing positive for Covid-19 among those with two doses of an mRNA Covid-19 vaccine.
The researchers retrospectively looked at a cohort of 39,000 patients who underwent pre-procedural molecular screening tests for Covid-19.
Over 48,000 screening tests were performed, including 3,000 on patients who had received at least one dose of an mRNA Covid-19 vaccine, they said.
According to the researchers, these screening tests were part of routine Covid-19 testing prior to treatments not related to Covid-19, such as surgeries and other procedures.
Patients in the vaccinated group had received at least one dose of a messenger RNA Covid-19 vaccine, they added.

[ad_2]

Source link

Filed Under: Marketing Tagged With: asymptomatic, Covid19, greatly, infection, Moderna, Pfizer, reduce, risk, study, vaccines

Primary Sidebar

Recent Posts

  • 10 Tips To Hire the Best Moving Company in 2022
  • Google I/O 2022 Registrations Are Now Open: What to Expect From the Annual Developers Conference
  • How to Get Google Phone Number Free in 2022
  • Jio Set Top Box Free Here: How to install Jio Fiber box?
  • Scenery Drawing For Kids & Scenery Drawing Easy And Beautiful
  • Email
  • Instagram
  • Twitter
  • YouTube

Pages

  • About Us
  • Contact US
  • Privacy Policy
  • Terms and Conditions

Recent Comments

  • What is disability insurance? 2021 » Earth Edition on Jio Set Top Box Free Here: How to install Jio Fiber box?
  • What is disability insurance? 2021 » Earth Edition on Movies Website Data 100+Posts backup file Free Download
  • What is burial insurance? » Earth Edition on Scenery Drawing For Kids & Scenery Drawing Easy And Beautiful
  • How are Costs, Insurability and Underwriting Defined in Life Insurance? » Earth Edition on How Guest Posting Can Maximize Your Audience
  • Feeling Homeowners Insurance Claim Forms » Earth Edition on How Guest Posting Can Maximize Your Audience

Categories

  • Keywords (6)
  • Marketing (85)
  • Quality Content (31)
  • Rankings (12)
  • Search Engines (25)
  • SEO Guides (24)

Copyright © 2022 WEB BLOGGING